Earth Science Tech, Inc. (ETST) Announces Second Quarter Fiscal 2023 Financial Results on November 14, 2022, Followed with a Conference Call and Webcast.
Earth Science Tech, Inc. (ETST) will announce its financial results for the second quarter of fiscal 2023, ending September 30, 2022, on November 14, 2022, at 4:00 PM ET. Following this, a conference call will be held at 5:00 PM ET to discuss the results, including highlights and future outlook. The Company is in a pending transaction to enter compounding pharmaceuticals and telemedicine, which indicates a strategic shift towards expanding its healthcare services.
- Pending acquisition of companies in the health and wellness sector.
- Plans to enter compounding pharmaceuticals and telemedicine through new subsidiaries.
- None.
Insights
Analyzing...
Doral, FL, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC: ETST) (“ETST” or the “Company”), a holding entity set to acquire companies in the health and wellness space currently in a pending transaction to enter compounding pharmaceuticals and telemedicine, today announced that the Company will release its financial results for its second quarter fiscal 2023 ended September 30, 2022 on November 14, 2022 at 4:00pm Eastern Time.
Conference Call and Webcast:
The Company will host a conference call and webcast to discuss its second fiscal quarter results, highlights, and outlook at 5:00 pm Eastern Time. To participate in the telephone conference call please dial in at least 15 minutes prior to start time.
Toll-Free Dial In: 1-800-660-6527
Conference Code: 151729
For those who will not be able to join, please email your questions to, info@earthsciencetech.com. The conference call will be recorded and can be accessed on the Company’s website Investor Relations tab.
About Earth Science Tech, Inc. (ETST)
Earth Science Tech, Inc. is a holding entity set to acquire companies in the health and wellness space, currently in a pending transaction to enter compounding Schedules II and III controlled medications through its pending wholly owned subsidiary RxCompoundstore.com, LCC. (“RxCompound”) and launching soon its pending wholly owned subsidiary Peaks Curative, LLC., a telemedicine platform affiliated with doctors for online prescriptions to be fulfilled by RxCompound,.
To learn more, please visit: www.EarthScienceTech.com
SAFE HARBOR ACT: Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, listing on the CSE, including words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and other similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.
Company Contact:
www.EarthScienceTech.com
Nickolas S. Tabraue
CEO & Director
nick@earthsciencetech.com
786.375.7281
FAQ
When will Earth Science Tech, Inc. (ETST) release its second quarter fiscal 2023 financial results?
What time is the Earth Science Tech, Inc. (ETST) conference call to discuss financial results?
What business areas is Earth Science Tech, Inc. (ETST) focusing on?
